Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising improvements across various professional medical and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, far more trusted substitute for therapeutic